Medical approaches to primary hyperparathyroidism.
Medical therapy is useful in cases of acute primary hyperparathyroidism, patients with recurrent disease, and parathyroid carcinoma. Among the therapeutic agents that have been employed, oral phosphate, bisphosphonates, and estrogens have been successful. The newly described calcimimetic agents directly block secretion of parathyroid hormone from the glands and offer an important new approach to medical therapy of primary hyperparathyroidism.
Strewler
G J
GJ
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
D002118:Calcium / Q000819:agonists / Q000502:physiology*; D004164:Diphosphonates / Q000627:therapeutic use*; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy*; D008297:Male; D018716:Molecular Mimicry; D010282:Parathyroid Neoplasms / Q000150:complications / Q000188:drug therapy; D010710:Phosphates / Q000627:therapeutic use*; D011372:Progestins / Q000627:therapeutic use*
D004164:Diphosphonates; D004967:Estrogens; D010710:Phosphates; D011372:Progestins; D002118:Calcium